[Federal Register Volume 78, Number 228 (Tuesday, November 26, 2013)] [Notices] [Page 70617] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2013-28447] [[Page 70617]] ----------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION [File No. 500-1] In the Matter of Pure H20 Bio-Technologies, Inc.; Order of Suspension of Trading November 22, 2013. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Pure H20 Bio-Technologies, Inc. because questions have arisen as to its operating status, if any. The Commission is of the opinion that the public interest and the protection of the investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed company is suspended for the period from 9:30 a.m. EST on November 22, 2013, through 11:59 p.m. EST on December 6, 2013. By the Commission. Jill M. Peterson, Assistant Secretary, [FR Doc. 2013-28447 Filed 11-22-13; 11:15 am] BILLING CODE 8011-01-P